SCRI at Mary Crowley

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Endometrial cancer1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Ovarian cancer1 trial
• Pancreatic cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 14 trials

Status

• Recruiting3 trials
• Not yet recruiting1 trial

Lead sponsor

• Context Therapeutics Inc.1 trial
• Evopoint Biosciences Inc.1 trial
• Janux Therapeutics1 trial
• TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)1 trial

Running trials

• Not yet recruiting

  Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer

  NCT07707674· Phase 1· Evopoint Biosciences Inc.· Source

  Contact: Reva Schneider, MD

• Recruiting

  Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

  NCT07545811· Phase 1· Janux Therapeutics· Source

  Contact: Janux Therapeutics, MD

• Recruiting

  Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  NCT06625775· Phase 1· TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)· Source

  Contact: BBOT (BridgeBio Oncology Therapeutics)

• Recruiting

  A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

  NCT06515613· Phase 1· Context Therapeutics Inc.· Source

  Contact: Angela Hotchkiss

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Endometrial cancer1 recruiting
• Lung cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Prostate cancer1 recruiting